Federal Circuit Reverses District Court’s Denial of JMOL and Finds That Semiconductor Patent Was Not Enabled Under 35 U.S.C. § 112

Aug 7, 2018

Reading Time : 2 min

The ’738 patent relates to the field of light-emitting diodes (LEDs), which are semiconductor devices that typically consist of multiple layers of solid-state materials. Claim 19, the only claim-at-issue, is directed to a semiconductor device that includes a growth layer “grown on” a non-single crystalline buffer layer. During claim construction, plaintiff-cross-appellant Boston University (BU) successfully argued that “grown on” meant “formed indirectly or directly above” the buffer layer and that “non-single crystalline buffer layer” meant a layer of material that is not monocrystalline. Based on this construction, Clamim 19 provided for six possible combinations of a growth layer and a buffer layer. The enablement issue here centered on whether the ’738 patent taught one of those combinations, namely, a monocrystalline growth layer formed directly on an amorphous buffer layer.

The defendant-appellants–Everlight, Epistar and Lite-On (collectively, “Defendants”) –argued that Claim 19 is not enabled because the ’738 patent’s specification does not teach one of skill in the art how to make the claimed semiconductor device with a monocrystalline growth layer grown directly on an amorphous buffer layer through epitaxy. In fact, Defendants’ expert testified that it is impossible to epitaxially grow a monocrystalline film directly on an amorphous structure, a statement with which BU’s expert agreed. Based on the expert testimony, the Federal Circuit concluded, “the specification does not enable what the experts agree is physically impossible.”

BU attempted to sidestep this shortcoming by arguing that the ’738 patent teaches other ways to grow a monocrystalline layer directly on an amorphous layer. The Federal Circuit rejected BU’s argument, noting that BU could not identify any passage of the specification that discloses how to grow a monocrystalline layer directly on an amorphous layer.

BU also pointed to testimony indicating that others have successfully grown a monocrystalline layer directly on an amorphous buffer layer. The district court acknowledged that the testing occurred after the ’738 issued, but admitted the evidence to rebut the argument that such growth was impossible. The Federal Circuit found this evidence to be nonprobative of enablement, reasoning that “[t]he inquiry is not whether it was, or is, possible to make the full scope of the claimed device . . . . The inquiry is whether the patent’s specification taught one of skill in the art how to make such a device without undue experimentation as of the patent’s effective filing date.”  Therefore, “[s]imply observing that it could be done—years after the patent’s effective filing date—bears little on the enablement inquiry.”

The court concluded that, “to some extent, BU created its own enablement problem” by seeking a specific claim construction, but failing to defend against an enablement challenge as to the claim’s full scope. That is, “if BU wanted to exclude others from what it regarded as its invention, its patent needed to teach the public how to make and use that invention. That is part of the quid pro quo of the patent bargain.”

Practice Tip:  Be careful what you wish for. This case provides a good example of how a successful argument in favor of a broad claim construction may backfire on a plaintiff if the patent fails to enable the full scope of the broad construction.

Trustees of Boston University. v. Everlight Electronics Co., Ltd., Everlight Americas, Inc., Epistar Corporation, Lite-On Inc., Lite-On Service USA, Inc., Lite-On Technology Corporation, Lite-On Trading USA, Inc., Nos. 2016-2576, 2016-2577, 2016-2578, 2016-2579, 2016-2580, 2016-2581, 2016-2582, 2016-2591, 2016-2592, 2016-2593, 2016-2594, 2016-2595 (Fed. Cir. July 25, 2018

Share This Insight

Categories

Previous Entries

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

IP Newsflash

December 5, 2025

District courts are split on whether a complaint can provide the required knowledge for post-suit indirect and willful infringement in that same lawsuit. Chief Judge Connolly in the District of Delaware recently confirmed that, consistent with his prior opinions, the complaint cannot serve as the basis for knowledge for either a claim of post-suit indirect infringement or a demand for willfulness-based enhanced damages in that lawsuit.

...

Read More

IP Newsflash

December 3, 2025

The Federal Circuit recently held that a patentee acted as its own lexicographer to define a claim term even though it did not explicitly define the term. Rather, because the patentee consistently and clearly used two terms interchangeably to describe the same structural feature and did so in all of the embodiments in which the feature appeared, the patentee impliedly gave the term its own, unique definition.

...

Read More

IP Newsflash

December 2, 2025

The Federal Circuit recently held an asserted patent was not entitled to its priority date because the priority application lacked written description support for the asserted claims. In so doing, the court explained that broad disclosures that do not provide reasonably specific support for narrower claims do not meet the written description requirement. The court also considered whether the inventor’s testimony showed they possessed the full scope of the claimed genus at the priority date or whether it was more likely the inventors first became aware of the claimed embodiments from public disclosures of the accused product.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.